✉news HealthNutrition first seen 4 d ago, last 4 d ago, peak #28
M42's IROS and 10XREVIV launch GLP-1 nutrition study
Original: M42’s IROS, 10XREVIV announce clinical study to evaluate precision nutrition for GLP-1 users
M42's IROS and 10XREVIV have announced a clinical study to evaluate precision nutrition approaches for people using GLP-1 medications. The research aims to assess how tailored nutrition plans can support patients on the weight-loss and diabetes drugs, a rapidly growing drug class. Details on study size, duration and locations were not disclosed in the announcement.
Why now: GLP-1 drugs are surging in popularity, drawing attention to complementary nutrition and health services targeting their users
Rank over time, top of the chart is #1. 2 snapshots from 4 d ago to 4 d ago.
Evidence
- M42’s IROS, 10XREVIV announce clinical study to evaluate precision nutrition for GLP-1 users · www.wam.ae
API: https://socialmediatrends-api.osmike.com/v1/trends/3736430